Association of Serum 1,25-Dihydroxyvitamin D Levels with Erythropoietin Resistance Index-Based Relative Erythropoiesis-Stimulating Agent Hyporesponsiveness in Pre-Dialysis Chronic Kidney Disease
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27188044 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Jun Yeong Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Vitamin D, Erythropoietin, Hematinics. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Erythropoiesis-stimulating agent (ESA) hyporesponsiveness is a major challenge in the management of anemia in chronic kidney disease (CKD). This study evaluated the association between serum 1,25-dihydroxyvitamin D [1,25(OH)2D] levels and ESA responsiveness in patients with pre-dialysis CKD. This retrospective cohort study included 363 adult patients with anemia and pre-dialysis CKD who received continuous erythropoietin receptor activator therapy for at least three months. ESA responsiveness was assessed using the erythropoietin resistance index (ERI). The highest ERI tertile was used to define ERI-based relative ESA hyporesponsiveness. Among 363 patients, 121 (33.3%) were classified as having relative ESA hyporesponsiveness. Serum 1,25(OH)2D levels were significantly lower in the relative ESA-hyporesponsive group. In multivariable analyses, lower serum 1,25(OH)2D levels were independently associated with relative ESA hyporesponsiveness and higher log-transformed ERI. Exploratory ROC analysis showed modest discriminative ability for identifying patients in the highest ERI tertile. Lower serum 1,25(OH)2D levels were independently associated with ERI-based relative ESA hyporesponsiveness in pre-dialysis CKD. These findings suggest that active vitamin D status may be linked to ESA responsiveness, as assessed by ERI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea.
- Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, Republic of Korea.
ORCID-Profile: Il Young Kim
Zitieren
APA
Kim, J. Y., Lee, D. W., Lee, S. B., & Kim, I. Y. (2026). Association of Serum 1,25-Dihydroxyvitamin D Levels with Erythropoietin Resistance Index-Based Relative Erythropoiesis-Stimulating Agent Hyporesponsiveness in Pre-Dialysis Chronic Kidney Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188044
Vancouver
Kim JY, Lee DW, Lee SB, Kim IY. Association of Serum 1,25-Dihydroxyvitamin D Levels with Erythropoietin Resistance Index-Based Relative Erythropoiesis-Stimulating Agent Hyporesponsiveness in Pre-Dialysis Chronic Kidney Disease. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188044
BibTeX
@article{Kim2026,
author = {Kim, Jun Yeong and Lee, Dong Won and Lee, Soo Bong and Kim, Il Young},
title = {Association of Serum 1,25-Dihydroxyvitamin D Levels with Erythropoietin Resistance Index-Based Relative Erythropoiesis-Stimulating Agent Hyporesponsiveness in Pre-Dialysis Chronic Kidney Disease},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27188044}
}
EUVIMED